Phase III trial of modulation of cisplatin/fluorouracil chemotherapy by interferon alfa-2b in patients with recurrent or metastatic head and neck cancer. Head and Neck Interferon Cooperative Study Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples